Exact Mass: 1522.836804
Exact Mass Matches: 1522.836804
Found 4 metabolites which its exact mass value is equals to given mass value 1522.836804,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-{3-[2-(2-{[(1-{[1-({1-[(1-{3-[2-(2-{[4-(1H-indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]piperidin-4-yl}carbonyl)piperidin-4-yl]carbonyl}piperidin-4-yl)carbonyl]amino}ethoxy)ethoxy]propanoyl}-N(6)-(5-nitro-2-furoyl)lysinamide
N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-{3-[2-(2-{[(1-{[1-({1-[(1-{3-[2-(2-{[4-(1H-indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]piperidin-4-yl}carbonyl)piperidin-4-yl]carbonyl}piperidin-4-yl)carbonyl]amino}ethoxy)ethoxy]propanoyl}-N(6)-(5-nitro-2-furoyl)lysinamide
Osteogenic Growth Peptide, OGP
Osteogenic Growth Peptide, OGP
Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations.
SWELYYPLRANL-NH2
SWELYYPLRANL-NH2
SWELYYPLRANL-NH2 is an E-cadherin and N-cadherin antagonist. SWELYYPLRANL-NH2 inhibits phage clone binding to E- or N-cad/Fc chimeric protein (IC50: 0.7 and 0.09 μM respectively). SWELYYPLRANL-NH2 inhibits cell aggregation. SWELYYPLRANL-NH2 can be used to promote drug delivery through epithelial and endothelial permeability barriers[1].
(2s)-2-[(2r,3r)-2-{[(2s)-2-[(2s)-2-{[(2r)-5-carbamimidamido-2-{[(2r,3r)-2-{[(2r,3r)-2-{[(2s,3s,4r)-2-{[(2r,3r,4s)-7-carbamimidamido-4-{[(2r)-2-{[(2r,3r,4r)-1,3-dihydroxy-2,4,6-trimethylheptylidene]amino}-1-hydroxypropylidene]amino}-1,2,3-trihydroxyheptylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)-3,4-dimethylbutylidene]amino}-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}-1-hydroxypentylidene]amino}-n,4-dimethylpentanamido]-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}-3-(4-hydroxyphenyl)-3-methoxy-n-methylpropanamido]propanoic acid
(2s)-2-[(2r,3r)-2-{[(2s)-2-[(2s)-2-{[(2r)-5-carbamimidamido-2-{[(2r,3r)-2-{[(2r,3r)-2-{[(2s,3s,4r)-2-{[(2r,3r,4s)-7-carbamimidamido-4-{[(2r)-2-{[(2r,3r,4r)-1,3-dihydroxy-2,4,6-trimethylheptylidene]amino}-1-hydroxypropylidene]amino}-1,2,3-trihydroxyheptylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)-3,4-dimethylbutylidene]amino}-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}-1-hydroxypentylidene]amino}-n,4-dimethylpentanamido]-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}-3-(4-hydroxyphenyl)-3-methoxy-n-methylpropanamido]propanoic acid